Haanen C - Search Results

1

Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.

Bär BM, de Witte T, de Pauw BE, Haanen C. Bär BM, et al. Among authors: haanen c. Neth J Med. 1990 Feb;36(1-2):19-24. Neth J Med. 1990. PMID: 2314517

2

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: haanen c. Cancer. 1990 Sep 1;66(5):831-7. doi: 10.1002/1097-0142(19900901)66:5<831::aid-cncr2820660503>3.0.co;2-e. Cancer. 1990. PMID: 2386911

3

Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: haanen c. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:33-5. Bone Marrow Transplant. 1989. PMID: 2697396 Clinical Trial.

4

In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia.

Raymakers R, De Witte T, Joziasse J, Van der Lely N, Boezeman J, Haanen C. Raymakers R, et al. Among authors: haanen c. Br J Haematol. 1991 May;78(1):35-41. doi: 10.1111/j.1365-2141.1991.tb04379.x. Br J Haematol. 1991. PMID: 2043479

5

Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery.

Van der Lely N, De Witte T, Raemaekers J, Schattenberg A, Haanen C. Van der Lely N, et al. Among authors: haanen c. Bone Marrow Transplant. 1989 Mar;4(2):163-6. Bone Marrow Transplant. 1989. PMID: 2650786

6

Diabetes insipidus associated with leukaemia.

Smits P, de Witte T, Haanen C, Fennis J. Smits P, et al. Among authors: haanen c. Neth J Med. 1989 Jun;34(5-6):264-9. Neth J Med. 1989. PMID: 2770937

7

Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.

Werter M, de Witte R, Janssen J, de Pauw B, Haanen C. Werter M, et al. Among authors: haanen c. Blut. 1988 May;56(5):209-12. doi: 10.1007/BF00320107. Blut. 1988. PMID: 3285912 Clinical Trial.

8

Remission-induction of acute lymphoblastic transformation of chronic myeloid leukaemia, followed by long-term maintenance therapy.

de Witte T, de Pauw B, Haanen C. de Witte T, et al. Among authors: haanen c. Blut. 1986 Apr;52(4):231-5. doi: 10.1007/BF00321082. Blut. 1986. PMID: 3457609

9

Prognostic factors in adult patients with acute leukemia at first relapse.

Smits P, Schoots L, de Pauw BE, de Witte T, Holdrinet RS, Janssen JT, Haanen C. Smits P, et al. Among authors: haanen c. Cancer. 1987 May 1;59(9):1631-4. doi: 10.1002/1097-0142(19870501)59:9<1631::aid-cncr2820590918>3.0.co;2-6. Cancer. 1987. PMID: 3470111

10

Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).

Raijmakers R, Speth P, de Witte T, Linssen P, Wessels J, Haanen C. Raijmakers R, et al. Among authors: haanen c. Br J Cancer. 1987 Aug;56(2):123-6. doi: 10.1038/bjc.1987.168. Br J Cancer. 1987. PMID: 3663464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters